Antibiotice Iasi 1Q Sales Drop 10% To RON66M, Net Profit Of RON4.03M, Close To Level In Year-Earlier Period

05.12.2021 By Ecaterina Craciun

Antibiotice Iasi (ATB.RO), the largest Romanian-held pharmaceutical producer, on Wednesday reported sales of RON66.1 million for the first quarter of 2021, down 10.2% on the year, and a net profit of RON4.03 million, which is close to the level reported in the same period in 2020.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

 
Keywords:
Antibiotice Iasi
, earnings